Antimicrobial Agents Practice Questions

Q: A 45-year-old man is placed on an antifungal agent for systemic infection and is noted to have decreased serum leukocyte and platelet counts. Bone marrow suppression is a common adverse effect of which of the following drugs?

Flucytosine. **Explanation:** **Flucytosine (5-Fluorocytosine)** is the correct answer. It is a pyrimidine antimetabolite that acts as a prodrug. Inside the fungal cell, it is converted by the enzyme **cytosine deaminase** into **5-fluorouracil (5-FU)**, which inhibits DNA and protein synthesis. While human cells lack cytosine deaminase, the intestinal flora can convert some flucytosine into 5-FU systemically. This leads to significant **bone marrow suppression** (leukopenia, thrombocytopenia, and anemia), which is its most characteristic and dose-limiting adverse effect. **Analysis of Incorrect Options:** * **Griseofulvin (A):** Primarily used for dermatophytosis. Its common side effects include headaches, GI upset, and photosensitivity. It is an inducer of Cytochrome P450. * **Terbinafine (B):** An allylamine that inhibits squalene epoxidase. It is most commonly associated with GI distress, taste disturbances, and rarely, hepatotoxicity, but not typically bone marrow suppression. * **Fluconazole (C):** An azole that inhibits ergosterol synthesis. It is generally well-tolerated; its main concerns are GI upset and inhibition of CYP3A4 enzymes. **High-Yield Clinical Pearls for NEET-PG:** * **Synergy:** Flucytosine is almost always used in combination with **Amphotericin B** (especially for Cryptococcal meningitis) to prevent the rapid development of resistance. * **Mechanism:** It inhibits **thymidylate synthase**, thereby halting DNA synthesis. * **Monitoring:** Patients on Flucytosine require regular **Complete Blood Counts (CBC)** to monitor for hematological toxicity. * **Renal Impairment:** Toxicity is significantly increased in patients with renal failure, as the drug is excreted unchanged by the kidneys.

Q: Which one of the following is a nucleoside analog reverse transcriptase inhibitor?

Zidovudine. ### Explanation **Correct Answer: C. Zidovudine** **Mechanism of Action:** Zidovudine (AZT) is a **Nucleoside Reverse Transcriptase Inhibitor (NRTI)** [2]. It is a structural analog of thymidine [1]. To become active, it must undergo intracellular phosphorylation by host cell kinases into its triphosphate form [1, 2]. It then competes with natural nucleotides for incorporation into the viral DNA chain by the enzyme **Reverse Transcriptase** [1]. Once incorporated, it causes **premature chain termination** because it lacks the 3'-OH group necessary for forming a phosphodiester bond [1]. **Analysis of Incorrect Options:** * **A & B (Efavirenz and Nevirapine):** These are **Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)** [2]. Unlike NRTIs, they do not require phosphorylation and do not compete with nucleotides. Instead, they bind directly to a non-catalytic "pocket" on the Reverse Transcriptase enzyme, causing a conformational change that inhibits its activity. * **D (Saquinavir):** This is a **Protease Inhibitor (PI)**. It inhibits the viral protease enzyme (HIV-1 protease), preventing the cleavage of gag-pol polyproteins into functional mature proteins, resulting in the production of immature, non-infectious virions. **Clinical Pearls for NEET-PG:** * **Zidovudine Side Effects:** The most characteristic side effect is **bone marrow suppression** (anemia and neutropenia). It is also associated with **myopathy** and nail hyperpigmentation. * **Prevention of Mother-to-Child Transmission (PMTCT):** Zidovudine was the first drug used to reduce vertical transmission of HIV. * **Mitochondrial Toxicity:** NRTIs can inhibit mitochondrial DNA polymerase-gamma, leading to lactic acidosis and hepatic steatosis (Stavudine > Zidovudine) [1]. * **Tenofovir:** Note that Tenofovir is a **Nucleotide** analog (already has one phosphate group), whereas Zidovudine is a **Nucleoside** analog.

Q: Which of the following conditions is NOT typically treated with azoles?

Cryptococcal meningitis. The correct answer is **Cryptococcal meningitis** because, while azoles (specifically Fluconazole) are used in the maintenance phase, they are **not** the treatment of choice for the induction phase of this life-threatening condition [1]. **1. Why Cryptococcal Meningitis is the correct answer:** The standard of care for the induction phase of Cryptococcal meningitis is a combination of **Amphotericin B and Flucytosine** [1]. Azoles are fungistatic and do not achieve rapid clearance of the fungus from the CSF. Although Fluconazole is used for long-term suppression (maintenance), it is insufficient as a primary treatment for the acute, severe stage of the disease [1]. **2. Why the other options are incorrect:** * **Chromomycosis:** Itraconazole is a first-line agent for this subcutaneous fungal infection, often combined with surgery or cryotherapy. * **Histoplasmosis:** Itraconazole is the drug of choice for mild-to-moderate cases [1]. Amphotericin B is reserved only for severe or disseminated disease. * **Paracoccidioidomycosis:** Itraconazole is considered the gold standard for treatment due to its high efficacy and lower toxicity compared to older sulfonamides. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice (DOC) for most systemic mycoses:** Itraconazole (e.g., Blastomycosis, Sporotrichosis, Histoplasmosis) [1]. * **Voriconazole:** DOC for **Invasive Aspergillosis** [3]. * **Fluconazole:** Notable for excellent CSF penetration [2], but its fungistatic nature limits its use in the induction phase of meningitis. * **Ketoconazole:** Now rarely used systemically due to its side effect profile (Cushing’s syndrome treatment, hepatotoxicity, and inhibition of steroidogenesis).

Q: Which of the following is NOT a known side effect of dapsone?

Myopathy. **Explanation:** Dapsone (Diaminodiphenyl sulfone) is a cornerstone in the treatment of leprosy and *Pneumocystis jirovecii* pneumonia. **Myopathy** is not a side effect of dapsone; it is more commonly associated with drugs like statins, colchicine, or zidovudine (AZT). **Analysis of Options:** * **Hemolytic Anemia (Option A):** This is the most common dose-related side effect. Dapsone causes oxidative stress on red blood cells. It is particularly severe in patients with **G6PD deficiency**, making G6PD screening essential before starting therapy. * **Hepatitis (Option C):** Dapsone can cause drug-induced liver injury, ranging from mild transaminitis to severe cholestatic jaundice as part of a hypersensitivity reaction. * **Infectious Mononucleosis-type Syndrome (Option D):** Also known as **"Dapsone Syndrome,"** this is a severe hypersensitivity reaction occurring 4–6 weeks after starting therapy. It is characterized by a triad of fever, malaise, and lymphadenopathy, often accompanied by jaundice and exfoliative dermatitis. It mimics infectious mononucleosis but is drug-induced. **High-Yield Clinical Pearls for NEET-PG:** * **Methemoglobinemia:** Dapsone frequently causes methemoglobinemia (presents as "chocolate-colored blood" and cyanosis). * **Lepra Reactions:** Dapsone is used in MDT for leprosy but does not prevent Type 1 or Type 2 lepra reactions. * **Mechanism:** It inhibits dihydropteroate synthase (folate synthesis inhibitor), similar to sulfonamides. * **Agranulocytosis:** A rare but life-threatening idiosyncratic reaction.

Q: All of the following are used in the treatment of Pneumocystis jirovecii pneumonia except?

Fluoroquinolones. **Explanation:** *Pneumocystis jirovecii* is a unique unicellular fungus that causes opportunistic pneumonia (PCP), primarily in immunocompromised patients (e.g., HIV/AIDS). Unlike most fungi, it lacks ergosterol in its cell membrane, making it resistant to standard antifungals like Amphotericin B or Azoles. **Why Fluoroquinolones are the Correct Answer:** Fluoroquinolones (e.g., Ciprofloxacin, Levofloxacin) act by inhibiting DNA gyrase and Topoisomerase IV in bacteria [1]. They have **no clinical activity** against *P. jirovecii*. Therefore, they are not used in the treatment or prophylaxis of PCP. **Analysis of Other Options:** * **Cotrimoxazole (Trimethoprim-Sulfamethoxazole):** This is the **drug of choice** for both treatment and prophylaxis of PCP [1, 5]. It works by inhibiting sequential steps in the folate synthesis pathway. * **Pentamidine:** An alternative agent used in patients who cannot tolerate Cotrimoxazole or in severe cases [2]. It is administered intravenously or via inhalation (though inhalation is less effective for treatment) [2]. * **Dapsone:** Often used in combination with Trimethoprim, it is an effective alternative for prophylaxis and mild-to-moderate treatment in patients with sulfonamide allergies. **High-Yield Clinical Pearls for NEET-PG:** 1. **First-line Treatment:** Cotrimoxazole (High dose: 15–20 mg/kg/day of TMP component) [3]. 2. **Steroid Indication:** In HIV patients, if $PaO_2 35$ mmHg, add corticosteroids to prevent clinical worsening due to inflammation from dying organisms [3]. 3. **Other Alternatives:** Atovaquone (mild cases) and Clindamycin + Primaquine (moderate-to-severe cases). 4. **Prophylaxis:** Indicated in HIV patients when CD4 count falls below **200 cells/µL**.

Q: A 15-year-old boy presents with a two-day history of fever, altered sensorium, and a purpuric rash. On examination, he is stuporous, with a BP of 90/60 mmHg and extensive palpable purpura on his legs. Which of the following would be the most appropriate initial choice of antibiotic?

Penicillin G. ### Explanation The clinical presentation of fever, altered sensorium, and a characteristic **purpuric rash** (especially palpable purpura) in a young patient is highly suggestive of **Meningococcemia** (caused by *Neisseria meningitidis*). This is a medical emergency that can rapidly progress to Waterhouse-Friderichsen syndrome and septic shock. **1. Why Penicillin G is the Correct Answer:** Historically and for exam purposes, **Penicillin G** remains the drug of choice for confirmed meningococcal infections. While third-generation cephalosporins (like Ceftriaxone) are often used empirically in clinical practice to cover both *S. pneumoniae* and *N. meningitidis*, Penicillin G is the classic, highly effective treatment for susceptible strains of *N. meningitidis*. It has excellent bactericidal activity and achieves therapeutic concentrations in the CSF when the meninges are inflamed. **2. Why the Other Options are Incorrect:** * **Vancomycin (A):** Primarily used for MRSA or resistant *S. pneumoniae*. It does not provide adequate coverage for Gram-negative diplococci like *N. meningitidis*. * **Ciprofloxacin (C):** While used for **prophylaxis** in close contacts of a patient with meningococcal meningitis, it is not the first-line agent for the treatment of the acute disease. * **Gentamicin (D):** An aminoglycoside used for Gram-negative enteric bacilli. It has poor CSF penetration and is ineffective against *N. meningitidis*. **3. NEET-PG High-Yield Pearls:** * **Drug of Choice (DOC) for Meningococcemia:** Penicillin G. * **DOC for Meningococcal Prophylaxis:** Rifampicin (most common), Ciprofloxacin, or Ceftriaxone. * **Classic Triad:** Fever, neck stiffness, and altered mental status (though the purpuric rash is the "giveaway" for Meningococcemia). * **Mechanism of Penicillin:** Inhibits bacterial cell wall synthesis by binding to Penicillin-Binding Proteins (PBPs) and inhibiting transpeptidation.

Q: Which of the following drugs is NOT effective in cases of Pneumocystis jirovecii pneumonia?

Cefepime. **Explanation:** *Pneumocystis jirovecii* is a unique unicellular fungus (formerly classified as a protozoan) that causes opportunistic pneumonia (PJP), primarily in immunocompromised patients such as those with HIV/AIDS. **Why Cefepime is the Correct Answer:** Cefepime is a **fourth-generation cephalosporin** antibiotic. Its mechanism of action involves inhibiting bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs). Since *Pneumocystis jirovecii* is a fungus and lacks a bacterial peptidoglycan cell wall, beta-lactam antibiotics like Cefepime have **no activity** against it. Cefepime is typically reserved for serious bacterial infections, including *Pseudomonas aeruginosa*. **Analysis of Other Options:** * **Pentamidine (Option A):** An aromatic diamidine used as an alternative for moderate-to-severe PJP in patients who cannot tolerate Co-trimoxazole. It can be administered intravenously or via aerosolized form. * **Trimethoprim-dapsone (Option B):** This combination is an effective oral regimen for mild-to-moderate PJP. Dapsone acts as a sulfonamide-like folate synthesis inhibitor. * **Clindamycin plus primaquine (Option C):** This is a standard alternative regimen for mild-to-severe PJP, especially in patients with sulfa allergies. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice (DOC):** Co-trimoxazole (Trimethoprim-Sulfamethoxazole) is the DOC for both prophylaxis and treatment of PJP. * **Prophylaxis Criteria:** In HIV patients, PJP prophylaxis is started when the **CD4 count falls below 200 cells/mm³**. * **Adjunctive Therapy:** Corticosteroids are added to the treatment regimen if the patient is hypoxic (PaO₂ 35 mmHg) to reduce inflammation caused by dying organisms. * **Diagnosis:** Silver stain (Gomori Methenamine Silver) showing "crushed ping-pong ball" appearance of cysts.

Q: Amphotericin B treatment mandates the monitoring of which of the following electrolytes?

Magnesium (Mg2+). **Explanation:** Amphotericin B is a potent antifungal agent known for its significant renal toxicity, often referred to as "Amphoterrible" due to its side effect profile. The drug causes nephrotoxicity through two mechanisms: direct toxicity to the renal tubular epithelium and pre-renal vasoconstriction. **Why Magnesium (Mg²⁺) is the correct answer:** Amphotericin B increases the permeability of the distal tubule and collecting duct. This leads to a "leak" of intracellular electrolytes into the tubular lumen, resulting in significant renal wasting of **Magnesium** (Hypomagnesemia) and **Potassium** (Hypokalemia). Monitoring and replacement of these electrolytes are mandatory during therapy to prevent cardiac arrhythmias and neuromuscular complications. **Analysis of Incorrect Options:** * **A. Sodium (Na⁺):** While Amphotericin B affects the kidneys, it does not typically cause significant clinical fluctuations in sodium levels that require the same level of intensive monitoring as magnesium or potassium. In fact, "saline loading" (giving normal saline) is actually used as a protective measure to reduce Amphotericin-induced nephrotoxicity. * **B. Calcium (Ca²⁺):** Although magnesium deficiency can secondary lead to hypocalcemia, calcium is not the primary electrolyte directly wasted by the renal tubules due to Amphotericin B. **High-Yield Clinical Pearls for NEET-PG:** * **Most common side effect:** Infusion-related reactions (fever, chills/rigors—"shake and bake" phenomenon). * **Most serious/dose-limiting side effect:** Nephrotoxicity (Azotemia). * **Electrolyte triad:** Hypomagnesemia, Hypokalemia, and Renal Tubular Acidosis (Type 1). * **Prevention:** Use of **Liposomal Amphotericin B** (decreases nephrotoxicity) and **Saline loading** before infusion.

Q: Which one of the following drugs is most likely to be associated with elevations of pancreatic enzymes, including amylase and lipase?

Didanosine. **Explanation:** **Didanosine (ddI)**, a Nucleoside Reverse Transcriptase Inhibitor (NRTI) used in HIV treatment, is classically associated with **acute pancreatitis** [1], [4]. The mechanism involves mitochondrial toxicity due to the inhibition of mitochondrial DNA polymerase-gamma [2], [4]. This leads to pancreatic acinar cell dysfunction, manifesting clinically as abdominal pain and significant elevations in serum **amylase and lipase** [1]. **Analysis of Options:** * **Didanosine (Correct):** Pancreatitis is its most serious dose-limiting toxicity (occurring in up to 7% of patients) [1], [3]. Risk is higher in patients with alcoholism, hypertriglyceridemia, or those co-administered with Stavudine. * **Erythromycin:** Primarily associated with GI upset (motilin receptor agonism) and **cholestatic hepatitis** (especially the estolate form), but not pancreatitis. * **Isoniazid (INH):** The hallmark side effect is **hepatotoxicity** and peripheral neuropathy (due to Vitamin B6 deficiency). While rare cases of INH-induced pancreatitis exist, it is not a classic or high-yield association compared to Didanosine. * **Azidothymidine (Zidovudine/AZT):** The major dose-limiting toxicities are **bone marrow suppression** (anemia, neutropenia) and myopathy. **NEET-PG High-Yield Pearls:** * **NRTI Class Side Effects:** Lactic acidosis and hepatic steatosis (due to mitochondrial toxicity) [2]. * **Specific NRTI Associations:** * **Didanosine/Stavudine:** Pancreatitis and Peripheral Neuropathy [4]. * **Zidovudine:** Anemia (Macrocytic). * **Abacavir:** Hypersensitivity reaction (linked to **HLA-B*5701**). * **Tenofovir:** Renal toxicity (Fanconi syndrome). * **Other Drugs causing Pancreatitis:** Valproate, Azathioprine, Sulfonamides, and Thiazides (Mnemonic: **"FAT SHEEP"** - Furosemide, Azathioprine, Thiazides, Sulfonamides, HCTZ, Estrogen, Enalapril, Pentamidine/Pentasa).

Question 1

A 45-year-old man is placed on an antifungal agent for systemic infection and is noted to have decreased serum leukocyte and platelet counts. Bone marrow suppression is a common adverse effect of which of the following drugs?

Accepted Answer

Flucytosine

Answer

Griseofulvin

Answer

Terbinafine

Answer

Fluconazole

Question 2

Which one of the following is a nucleoside analog reverse transcriptase inhibitor?

Accepted Answer

Zidovudine

Answer

Efavirenz

Answer

Nevirapine

Answer

Saquinavir

Question 3

Which of the following conditions is NOT typically treated with azoles?

Accepted Answer

Cryptococcal meningitis

Answer

Chromomycosis

Answer

Histoplasmosis

Answer

Paracoccidioidomycosis

Question 4

Which of the following is NOT a known side effect of dapsone?

Accepted Answer

Myopathy

Answer

Hemolytic anemia

Answer

Hepatitis

Answer

Infectious mononucleosis type syndrome

Question 5

All of the following are used in the treatment of Pneumocystis jirovecii pneumonia except?

Accepted Answer

Fluoroquinolones

Answer

Pentamidine

Answer

Dapsone

Answer

Cotrimoxazole

Question 6

A 15-year-old boy presents with a two-day history of fever, altered sensorium, and a purpuric rash. On examination, he is stuporous, with a BP of 90/60 mmHg and extensive palpable purpura on his legs. Which of the following would be the most appropriate initial choice of antibiotic?

Accepted Answer

Penicillin G

Answer

Vancomycin

Answer

Ciprofloxacin

Answer

Gentamicin

Question 7

Which of the following drugs is NOT effective in cases of Pneumocystis jirovecii pneumonia?

Accepted Answer

Cefepime

Answer

Pentamidine

Answer

Trimethoprim-dapsone

Answer

Clindamycin plus primaquine

Question 8

Which one of the following is a mechanism underlying the resistance of strains of S. pneumoniae to the widely used antibiotic, ciprofloxacin?

Accepted Answer

Reduced topoisomerase sensitivity to inhibitors

Answer

Increased synthesis of PABA

Answer

Formation of methyltransferases that change receptor structure

Answer

Structural changes in porins

Question 9

Amphotericin B treatment mandates the monitoring of which of the following electrolytes?

Accepted Answer

Magnesium (Mg2+)

Answer

Sodium (Na+)

Answer

Calcium (Ca2+)

Answer

None of the above

Question 10

Which one of the following drugs is most likely to be associated with elevations of pancreatic enzymes, including amylase and lipase?

Accepted Answer

Didanosine

Answer

Erythromycin

Answer

Isoniazid

Answer

Azidothymidine

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?